BioSpace News Archive

Newron today announced that Bo Jesper Hansen has informed the Board of Directors of his intention to step down as a Non-Executive Director, effective from this year’s Annual Shareholders Assembly taking place on March 27, 2018.

California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, honored three California state legislators as Life Sciences Champions during its Back to Session Reception in Sacramento that took place on February 7.

Confluent Medical Technologies completed the acquisition of Corpus Medical. Confluent Medical is a contract manufacturer with full scale capabilities to provide high-quality, low cost finished class III medical devices.

The offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Vyera Pharma announced the initiation of a Phase 1 single ascending dose study of TUR-006.

Dr. DeFord has more than 25 years of experience in the medical device industry, with particular expertise overseeing clinical advancement through innovative R&D and technology-based initiatives.

Bruker today announced financial results for its fourth quarter and fiscal year ended December 31, 2017.

The results were presented at the ASCO GU in San Francisco and were simultaneously published in The New England Journal of Medicine.

Intersect ENT today announced that it will release financial results for its fourth quarter and year 2017 on February 27, 2018.

Gilead Sciences announced that Norbert W. Bischofberger, PhD, Gilead’s Executive Vice President, R&D and Chief Scientific Officer, and Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the RBC Capital Markets 2018 Global Healthcare Conference in New York on Wednesday, February 21 at 9:00 a.m. Eastern Time.